Factor Xa Inhibitor-Related Intracranial Hemorrhage
Nicholas Panos(Rush University Medical Center), Bethany Sheahan, Philip E. Tobias, Scott T. May, Hallie Kelly, Christian W. Hamm(Justus-Liebig-Universität Gießen), Vasisht Srinivasan, Ron Neyens, Nirali Kalaria, Christopher J. Burdick, Leana Mahmoud, Benjamin Motley, Aaron M. Cook(University of Kentucky), Jamie M. Rosini, G. Morgan Jones(Methodist Le Bonheur Healthcare), Benjamin P. George(University of Rochester), Mehrnaz Pajoumand, Casey C. May(The Ohio State University Wexner Medical Center), Meena Thatikunta, Michael Erdman, Abdalla Ammar(NewYork–Presbyterian Hospital), Mathew Jones(Methodist University Hospital), Tamara Strohm(University of North Carolina at Chapel Hill), Gary D. Peksa(Rush University Medical Center), Farhad Bahrassa, Michael Armahizer(University of Maryland, Baltimore), Kendra J. Schomer, Laurel Jakubowski, Lori Wetmore, Keaton S. Smetana, Kent A. Owusu, Brian W. Gilbert, Richard Choi(Cornell University), Ryan C. Martin, Jason Mackey, Joshua M. DeMott, Charles Andrews(Boehringer Ingelheim (United States)), Deidre J. Rohaley, Eugene I. Lin, Ivan Da Silva(University of Florida), Omar J. Martinez, Sayona John(Rush University Medical Center), Mohammed Rehman(Henry Ford Hospital), Keith Nguyen, Philip M. Ross, Shaun Keegan, Lindsay Urben, Christine Frick, K. Ashley Sowers, Samantha Delibert
Cited by 106
Related Papers
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
Heart Disease and Stroke Statistics—2021 Update
|Circulation|2021|5.7k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes
|Circulation|2003|1k
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events
|New England Journal of Medicine|2013|825